Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1L - Antineoplastic and immunomodulating agents----1件: 85 💬
2L 44----1件: 96 💬
3L acetyl carnitine----1件: 13 💬
4L-000124467----2件: 13, 46 💬
5L-000124467 (freebase)----1件: 46 💬
6L-000124467-009J (succinat----1件: 46 💬
7L-000883191----1件: 46 💬
8L-001069957----1件: 46 💬
9L-123 Ioflupane----1件: 6 💬
10L-3-(3,4-Dihydroxyphenyl)alanine1件: Alanine1件: Alanine 💬 --1件: 6 💬
11L-883191----1件: 46 💬
12L-AA----1件: 240 💬
13L-alanine1件: Alanine1件: Alanine 💬 --1件: 299 💬
14L-Arginin-hydrochlorid-einmolar Fresenius----1件: 65 💬
15L-arginine2件: Arginine,
L-arginine		3件: Arginine hydrochloride ,
Arginine ,
Arginine hydrochloride 💬 		--10件: 2, 21, 46, 67, 96, 97, 98, 113, 223, 299 💬
16L-Carnitine----5件: 13, 46, 86, 96, 240 💬
17L-Carnitine Injection,1000mg once daily----1件: 2 💬
18L-Citrulline1件: Citrulline2件: L-Citrulline ,
Citrulline malate 💬 		--1件: 21 💬
19L-Citrulline and Metformin & L-Citrulline2件: Citrulline,
Metformin		4件: Metformin hydrochloride ,
Metformin ,
L-Citrulline ,
Citrulline malate 💬 		2件: PRKAA1,
PRKAA2 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113 💬
20L-Citrulline Malate1件: Citrulline2件: L-Citrulline ,
Citrulline malate 💬 		--1件: 86 💬
21L-CsA----1件: 228 💬
22L-DOPA1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
23L-Dopa/ MODOPAR----1件: 6 💬
24L-DOPA/DDCI----1件: 6 💬
25L-DOPS----1件: 6 💬
26L-fucose1件: Fucose1件: Elfucose 💬 --2件: 65, 248 💬
27L-Glutamine1件: L-Glutamine1件: Glutamine 💬 --2件: 113, 299 💬
28L-Histidine1件: Histidine1件: Histidine 💬 --1件: 13 💬
29L-Lactic acid2件: L-Lactic acid,
Lactic acid		2件: Lactic acid ,
Sodium lactate 💬 		--1件: 265 💬
30L-leucine1件: Leucine1件: Leucine 💬 --1件: 284 💬
31L-Lysine N acetylcysteinate1件: Lysine4件: Lysine acetate ,
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬 		--1件: 299 💬
32L-Lysine N-acetylcysteinate1件: Lysine4件: Lysine acetate ,
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬 		--1件: 299 💬
33L-Lysine- N-acetylcysteinate1件: Lysine4件: Lysine acetate ,
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬 		--1件: 299 💬
34L-Lysine-N-acetyl-L-cysteinate1件: Lysine4件: Lysine acetate ,
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬 		--1件: 299 💬
35L-Lysine-N-acetylcysteinate1件: Lysine4件: Lysine acetate ,
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬 		--1件: 299 💬
36L-Lysyl-D-Prolyl-L-Threonine Acetate2件: Acetate,
Threonine		1件: Threonine 💬 --1件: 97 💬
37L-Lysyl-D-Prolyl-LThreonine acetate, lyophilisate1件: Acetate---1件: 97 💬
38L-methionine1件: Methionine1件: Methionine 💬 --1件: 84 💬
39L-METHIONINE ([11C]METHYL)1件: Methionine1件: Methionine 💬 --1件: 84 💬
40L-Serine1件: Serine1件: Serine 💬 --1件: 2 💬
41L-Threo DOPS----1件: 17 💬
42L-tyrosine1件: Tyrosine1件: Tyrosine 💬 --2件: 6, 111 💬
43L0006CP03A----1件: 75 💬
44L01 - Antineoplastic agents----1件: 85 💬
45L0122----1件: 279 💬
46L0133----1件: 50 💬
47L01AA03----1件: 28 💬
48L01BA----1件: 96 💬
49L01BA01----2件: 46, 107 💬
50L01BB04----1件: 13 💬
51L01FC01----1件: 63 💬
52L01X - Other antineoplastic agents----1件: 85 💬
53L01X CO2----1件: 46 💬
54L01XC02----1件: 46 💬
55L01XE - Protein kinase inhibitors----1件: 85 💬
56L01XE01----1件: 86 💬
57L01XE31 - Nintedanib1件: Nintedanib2件: Nintedanib esylate ,
Nintedanib 💬 		8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬 		36件: Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 85 💬
58L03 AB----1件: 13 💬
59L03 AB 08----1件: 13 💬
60L03 AB07----1件: 13 💬
61L03AB13----1件: 13 💬
62L04 AB04----1件: 46 💬
63L04041)----1件: 46 💬
64L04AA04 - IMMUNOGLOBULINA ANTITIMOCITARIA (DI CONIGLIO) IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI THYMOGLOBULINE----1件: 13 💬
65L04AA10----2件: 278, 280 💬
66L04AA11----1件: 46 💬
67L04AA18----1件: 158 💬
68L04AA24----2件: 46, 271 💬
69L04AA25----1件: 62 💬
70L04AA26----1件: 49 💬
71L04AA31----1件: 13 💬
72L04AB0----2件: 46, 271 💬
73L04AB01----2件: 46, 271 💬
74L04AB04----5件: 46, 96, 107, 160, 271 💬
75L04AB05----2件: 46, 271 💬
76L04AC06----2件: 44, 45 💬
77L04AC07----2件: 41, 46 💬
78L04AX01----1件: 96 💬
79L04AX03----1件: 46 💬
80L2-01 adipose-derived mesenchymal stem cells (MSC)----1件: 96 💬
81L606 (Liposomal Treprostinil) Inhalation Solution 51ug1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
82L606 Inhalation System----1件: 86 💬
83L608 Inhalation Solution----1件: 86 💬
84L608 Liposomal inhalation suspension----1件: 86 💬
85LA294----1件: 49 💬
86LABA/LAMA----1件: 299 💬
87Lacosamide1件: Lacosamide1件: Lacosamide 💬 2件: SCN3A,
SCN9A 💬 		1件: Taste transduction 💬4件: 2, 46, 149, 298 💬
88Lacripep1件: Lacripep---1件: 53 💬
89Lacryvisc----1件: 53 💬
90Lactated Ringer----1件: 296 💬
91Lactated Ringers----2件: 96, 97 💬
92Lacteol forte capsules----1件: 49 💬
93Lactibane Iki----1件: 13 💬
94Lactic acid1件: Lactic acid2件: Lactic acid ,
Sodium lactate 💬 		--3件: 46, 265, 299 💬
95Lactic acid producing organisms1件: Lactic acid2件: Lactic acid ,
Sodium lactate 💬 		--1件: 299 💬
96Lactizole nebulization----1件: 299 💬
97Lactobacillus----1件: 51 💬
98Lactobacillus acidophilus1件: Lactobacillus acidophilus1件: Lactomin 💬 --1件: 6 💬
99Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers1件: Lactobacillus acidophilus1件: Lactomin 💬 --1件: 6 💬
100Lactobacillus casei1件: Lactobacillus casei1件: Lactobacillus casei 💬 --3件: 6, 97, 296 💬
101Lactobacillus casei DG1件: Lactobacillus casei1件: Lactobacillus casei 💬 --1件: 97 💬
102Lactobacillus casei DG (Enterolactis duo®)1件: Lactobacillus casei1件: Lactobacillus casei 💬 --1件: 6 💬
103Lactobacillus casei rhamnosus (Lcr35)1件: Lactobacillus casei1件: Lactobacillus casei 💬 --1件: 296 💬
104Lactobacillus GG----1件: 97 💬
105Lactobacillus paracasei1件: Lactobacillus paracasei---1件: 79 💬
106Lactobacillus paracasei B210601件: Lactobacillus paracasei---1件: 79 💬
107Lactobacillus plantarum1件: Lactobacillus plantarum---3件: 6, 97, 156 💬
108Lactobacillus plantarum PS1281件: Lactobacillus plantarum---1件: 6 💬
109LACTOBACILLUS REUTERI1件: Lactobacillus reuteri---2件: 97, 299 💬
110Lactobacillus rhamnosus----1件: 299 💬
111Lactobacillus rhamnosus CALM 607(LR607)----1件: 97 💬
112Lactobacillus Rhamnosus GG----2件: 13, 299 💬
113Lactobacillus rhamnosus GG ATCC 53103----1件: 97 💬
114Lactobacillus salivarius UCC118----2件: 96, 97 💬
115Lactobacilus acidophilus & bifidobacterium animalis/lactis----1件: 97 💬
116Lactoferrin1件: Lactoferrin---1件: 97 💬
117Lactose1件: Lactose2件: Anhydrous lactose ,
Lactose hydrate 💬 		--8件: 2, 6, 13, 21, 97, 107, 228, 310 💬
118Lactose in water2件: Lactose,
Water		3件: Water ,
Anhydrous lactose ,
Lactose hydrate 💬 		--1件: 97 💬
119Lactose monohydrate1件: Lactose2件: Anhydrous lactose ,
Lactose hydrate 💬 		--1件: 13 💬
120Lactose Sachet1件: Lactose2件: Anhydrous lactose ,
Lactose hydrate 💬 		--1件: 97 💬
121Lactulose1件: Lactulose1件: Lactulose 💬 --5件: 6, 13, 96, 97, 291 💬
122Lactulose/Rhamnose solution2件: Lactulose,
Rhamnose		1件: Lactulose 💬 --1件: 96 💬
123Ladarixin1件: Ladarixin---1件: 162 💬
124Lademirsen1件: Lademirsen---1件: 218 💬
125Lademirsen (SAR339375)1件: Lademirsen---1件: 218 💬
126LADICell----1件: 65 💬
127LAM-001----1件: 228 💬
128LAM-002A----1件: 2 💬
129LAMAZYM1件: Velmanase alfa1件: Velmanase alfa 💬 1件: MAN2B1 💬 2件: Lysosome biogenesis, Other glycan degradation 💬1件: 19 💬
130Lamictal----1件: 144 💬
131Lamivudine1件: Lamivudine1件: Lamivudine 💬 --10件: 2, 26, 42, 46, 49, 135, 156, 223, 265, 325 💬
132Lamivudine (3TC)1件: Lamivudine1件: Lamivudine 💬 --1件: 325 💬
133Lamivudine/Zidovudine2件: Lamivudine,
Zidovudine		2件: Lamivudine ,
Zidovudine 💬 		--1件: 265 💬
134Lamotrigin----2件: 34, 195 💬
135Lamotrigin actavis----3件: 113, 114, 115 💬
136Lamotrigin beta----2件: 34, 195 💬
137Lamotrigin ”Nordic Prime 100 mg----2件: 114, 115 💬
138Lamotrigin ”Nordic Prime 25 mg----2件: 114, 115 💬
139Lamotrigin ”Nordic Prime 50 mg----2件: 114, 115 💬
140Lamotrigine1件: Lamotrigine1件: Lamotrigine 💬 6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬7件: 13, 34, 38, 113, 114, 115, 144 💬
141Lamotrigine - generic product1件: Lamotrigine1件: Lamotrigine 💬 6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 38 💬
142Lamotrigine 25Mg Oral Tablet, Extended Release1件: Lamotrigine1件: Lamotrigine 💬 6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 114 💬
143Lamotrigine dispers1件: Lamotrigine1件: Lamotrigine 💬 6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 34 💬
144Lamotrigine extended release tablets1件: Lamotrigine1件: Lamotrigine 💬 6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 13 💬
145LANADELUMAB1件: Lanadelumab1件: Lanadelumab 💬 1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
146Lanadelumab 150 mg1件: Lanadelumab1件: Lanadelumab 💬 1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
147Lanadelumab 300 mg1件: Lanadelumab1件: Lanadelumab 💬 1件: KLKB1 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
148Land exercises----1件: 46 💬
149Landmark-based intrathecal administration of nusinersen1件: Nusinersen2件: Nusinersen sodium ,
Nusinersen 💬 		--1件: 3 💬
150LANIFIBRANOR1件: Lanifibranor1件: Lanifibranor 💬 3件: PPARA,
PPARD,
PPARG 💬 		22件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬1件: 51 💬
151Lanraplenib1件: Lanraplenib1件: Lanraplenib 💬 --2件: 53, 222 💬
152LANREOTIDA----1件: 77 💬
153Lanreotida Autogel 120 mg----1件: 77 💬
154Lanreotide1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 67, 73, 77, 85, 298 💬
155Lanreotide (Autogel formulation)1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
156Lanreotide (Autogel formulation), duration of treatment 24-56 weeks, depending on dose interval1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
157Lanreotide (Autogel formulation), duration of treatment 46-48 weeks1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
158Lanreotide 60Mg Solution for Injection1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
159LANREOTIDE ACETATE2件: Acetate,
Lanreotide		1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬4件: 67, 77, 85, 298 💬
160LANREOTIDE ACETATO1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
161Lanreotide ATG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
162Lanreotide ATG 120mg1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
163Lanreotide autogel1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
164Lanreotide Autogel 120 mg1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
165Lanreotide Autogel 120mg1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
166Lanreotide Autogel and Octreotide LAR2件: Lanreotide,
Octreotide		6件: Octreotide ,
Octreotide acetate ,
Lanreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
167Lanreotide Autogel®1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
168Lanreotide PRF1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
169Lanreotide-Autogel 120 mg1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
170Lansolprazole----1件: 166 💬
171Lansoprazole1件: Lansoprazole1件: Lansoprazole 💬 2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬8件: 63, 71, 85, 98, 166, 222, 223, 299 💬
172Lansoprazole 30mg1件: Lansoprazole1件: Lansoprazole 💬 2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 166 💬
173Lansoprazole, amoxicillin, clarithromycin3件: Amoxicillin,
Clarithromycin,
Lansoprazole		5件: Amoxicillin ,
Clarithromycin ,
Lansoprazole ,
Amoxicillin sodium ,
Amoxicillin 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬2件: 222, 223 💬
174Lansoprazole, clarithromycin, amoxycillin2件: Clarithromycin,
Lansoprazole		2件: Clarithromycin ,
Lansoprazole 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 63 💬
175Lantarel----1件: 46 💬
176Lantus 100 units/ml solution for injection in a cartridge----1件: 299 💬
177LANTUS*SC 5CAR3ML100UI/ML----1件: 299 💬
178Lantus® 100 Units/ml solution for injection in a vial. Lantus® 100 Units/ml solution for injection in a cartridge. Lantus® 100 Units/ml solution for injection in a pre-filled pen----1件: 299 💬
179Lap TAP Bupivacaine/Epinephrine2件: Bupivacaine,
Epinephrine		5件: Epinephrine ,
Epinephrine hydrochloride ,
Bupivacaine hydrochloride ,
Epinephrine bitartrate ,
Bupivacaine 💬 		15件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		20件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 96, 97 💬
180Lapaquistat1件: Lapaquistat---1件: 79 💬
181Lapaquistat acetate and current lipid-lowering treatment2件: Acetate,
Lapaquistat		---1件: 79 💬
182Lapatinib1件: Lapatinib2件: Lapatinib ditosylate ,
Lapatinib 💬 		2件: EGFR,
ERBB2 💬 		50件: Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, Virion - Hepatitis viruses 💬3件: 34, 74, 75 💬
183Lapine T-Lymphocyte Immune Globulin----4件: 62, 65, 284, 286 💬
184LAQUINIMOD1件: Laquinimod1件: Laquinimod sodium 💬 --4件: 8, 13, 49, 96 💬
185Laquinimod 0.31件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
186Laquinimod 0.61件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
187Laquinimod 1.21件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
188Laquinimod Capsulas 0.6 mg1件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
189Laquinimod Capsules 0.3 mg1件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
190Laquinimod capsules 0.5 mg1件: Laquinimod1件: Laquinimod sodium 💬 --2件: 8, 96 💬
191Laquinimod Capsules 0.6 mg1件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
192Laquinimod Cápsulas 0.5 mg1件: Laquinimod1件: Laquinimod sodium 💬 --1件: 96 💬
193Laquinimod Sodium (USAN)1件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
194Laquinimod Tablets 0.3 mg1件: Laquinimod1件: Laquinimod sodium 💬 --1件: 13 💬
195Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP4件: Dapsone,
Mycophenolate mofetil,
Prednisolone,
Triamcinolone		8件: Triamcinolone ,
Prednisolone ,
Dapsone ,
Mycophenolate mofetil ,
Triamcinolone acetonide ,
Triamcinolone diacetate ,
Triamcinolone hexacetonide ,
Mycophenolate mofetil hydrochloride 💬 		3件: IMPDH1,
IMPDH2,
NR3C1 💬 		3件: Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬1件: 162 💬
196Large Neutral Amino Acid Therapy----1件: 240 💬
197Large protein molecule----1件: 46 💬
198Lariam----1件: 25 💬
199LARONIDASE1件: Laronidase1件: Laronidase 💬 1件: IDUA 💬 2件: Glycosaminoglycan degradation, Lysosome biogenesis 💬2件: 19, 256 💬
200Laronidase ERT1件: Laronidase1件: Laronidase 💬 1件: IDUA 💬 2件: Glycosaminoglycan degradation, Lysosome biogenesis 💬1件: 19 💬
201Laronidase therapy and a stem cell transplant1件: Laronidase1件: Laronidase 💬 1件: IDUA 💬 2件: Glycosaminoglycan degradation, Lysosome biogenesis 💬1件: 19 💬
202Laropiprant1件: Laropiprant1件: Laropiprant 💬 1件: PTGDR 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 79 💬
203Laser doppler vibrometry (LDV), heart(cordium) carotid pulse wave velocity (ccPWV)----1件: 167 💬
204Late biologic therapy----1件: 96 💬
205Latozinemab1件: Latozinemab1件: Latozinemab 💬 1件: SORT1 💬 3件: Cholesterol metabolism, Lysosome biogenesis, Neurotrophin signaling pathway 💬1件: 127 💬
206Latrepirdine1件: Latrepirdine2件: Latrepirdine ,
Latrepirdine dihydrochloride 💬 		6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
207LAU-7b----1件: 299 💬
208Lavender oil1件: Lavender oil1件: Lavender oil 💬 --1件: 13 💬
209LAX-1011件: LAX-101---1件: 8 💬
210Laxabon----1件: 96 💬
211LB-P6----1件: 46 💬
212LB-P81件: LB-P8---2件: 46, 94 💬
213LB-P8 high-dose1件: LB-P8---1件: 94 💬
214LB-P8 low-dose1件: LB-P8---1件: 94 💬
215LBAL----1件: 46 💬
216LBEC0101----1件: 46 💬
217LBL-047 for Injection----1件: 49 💬
218LBS-008, BPN-14967----1件: 301 💬
219LBT-3627----1件: 6 💬
220LC51-0255----1件: 97 💬
221LCAR-AIO T cells----3件: 11, 13, 49 💬
222LCI699----1件: 75 💬
223LCI699, 1 mg----1件: 75 💬
224LCI699, 10 mg----1件: 75 💬
225LCI699, 20 mg----1件: 75 💬
226LCI699, 5 mg----1件: 75 💬
227LCIG----1件: 6 💬
228LCIG (Duodopa)----1件: 6 💬
229LCP-Tacro (tacrolimus)1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 95 💬
230LCZ696----1件: 58 💬
231LCZ696 100 mg----1件: 58 💬
232LCZ696 200 mg----1件: 58 💬
233LCZ696 50 mg----1件: 58 💬
234LD / BE----1件: 6 💬
235LD and GC012F CAR-T Cell Injection1件: GC012F---1件: 46 💬
236LD+DDCI----1件: 6 💬
237LD-aminopterin1件: Aminopterin1件: Aminopterin sodium 💬 --1件: 46 💬
238LD-DDCI----1件: 6 💬
239LD/CD----1件: 6 💬
240LD/CD SC solution----1件: 6 💬
241LDP-02----2件: 96, 97 💬
242LE051----1件: 113 💬
243Lead Candidate----1件: 5 💬
244LEBRIKIZUMAB1件: Lebrikizumab1件: Lebrikizumab 💬 1件: IL13 💬 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬1件: 85 💬
245Lecanemab1件: Lecanemab1件: Lecanemab 💬 1件: APP 💬 4件: Alzheimer disease, IgSF CAM signaling, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse 💬1件: 6 💬
246LECIG (levodopa, carbidopa, entacapone intestinal gel)3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
247Lecithin1件: Lecithin1件: Lecithin 💬 --1件: 340 💬
248Lederspan----1件: 107 💬
249Ledertrexate----1件: 46 💬
250Ledertrexato----1件: 46 💬
251Ledertrexato 2,5 mg comprimés----1件: 46 💬
252Ledipasvir1件: Ledipasvir1件: Ledipasvir 💬 --1件: 19 💬
253Ledipasvir/Sofosbuvir2件: Ledipasvir,
Sofosbuvir		2件: Sofosbuvir ,
Ledipasvir 💬 		--1件: 19 💬
254Lefamulin1件: Lefamulin2件: Lefamulin ,
Lefamulin acetate 💬 		--1件: 299 💬
255Leflunomide1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬14件: 11, 40, 46, 49, 53, 54, 66, 107, 162, 223, 224, 270, 271, 300 💬
256Leflunomide (permitted, not necessary)1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 46 💬
257Leflunomide 10 milligram (MG)1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 46 💬
258Leflunomide 20 mg Tablets (Geneva Pharmaceutical)1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 46 💬
259Leflunomide 20 mg+prednisone 0.5mg/kg/d2件: Leflunomide,
Prednisone		2件: Prednisone ,
Leflunomide 💬 		2件: DHODH,
NR3C1 💬 		2件: Neuroactive ligand-receptor interaction, Pyrimidine metabolism 💬2件: 66, 223 💬
260Leflunomide 20Mg Tab1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 46 💬
261Leflunomide 20mg/d1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 53 💬
262Leflunomide Mylan1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 53 💬
263Leflunomide plus Methotrexate2件: Leflunomide,
Methotrexate		3件: Methotrexate ,
Leflunomide ,
Methotrexate sodium 💬 		3件: DHFR,
DHFR2,
DHODH 💬 		4件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate, Pyrimidine metabolism 💬1件: 107 💬
264Leflunomide(LEF)1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬2件: 40, 224 💬
265Leflunomide-Sulfasalazine-Hydroxychloroquine3件: Hydroxychloroquine,
Leflunomide,
Sulfasalazine		4件: Sulfasalazine ,
Leflunomide ,
Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		1件: DHODH 💬 1件: Pyrimidine metabolism 💬1件: 46 💬
266Leflunomidum----1件: 46 💬
267Lemborexant1件: Lemborexant1件: Lemborexant 💬 2件: HCRTR1,
HCRTR2 💬 		2件: Hormone signaling, Neuroactive ligand-receptor interaction 💬2件: 6, 127 💬
268Lemborexant 5 MG1件: Lemborexant1件: Lemborexant 💬 2件: HCRTR1,
HCRTR2 💬 		2件: Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 127 💬
269Lemtrada----2件: 13, 65 💬
270LEMTRADA 12 mg Konzentrat zur Herstellung einer Infusionslösung----1件: 13 💬
271Lenabasum1件: Lenabasum1件: Lenabasum 💬 1件: CNR2 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 50, 51, 299 💬
272Lenabasum 20 mg1件: Lenabasum1件: Lenabasum 💬 1件: CNR2 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 51, 299 💬
273Lenabasum 20 mg Powder in Capsule1件: Lenabasum1件: Lenabasum 💬 1件: CNR2 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 51 💬
274Lenabasum 5 mg1件: Lenabasum1件: Lenabasum 💬 1件: CNR2 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 51, 299 💬
275Lenabasum 5 mg Powder in Capsule1件: Lenabasum1件: Lenabasum 💬 1件: CNR2 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 51 💬
276Lenabasum 5mg Powder in Capsule1件: Lenabasum1件: Lenabasum 💬 1件: CNR2 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 51 💬
277Lenadogene nolparvovec1件: Lenadogene nolparvovec---1件: 302 💬
278Lenalidomide1件: Lenalidomide1件: Lenalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬9件: 16, 26, 28, 34, 49, 56, 284, 300, 331 💬
279Lenalidomide 10 mg1件: Lenalidomide1件: Lenalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 56 💬
280Lenalidomide 25mg1件: Lenalidomide1件: Lenalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
281Lenalidomide and dexamethasone2件: Dexamethasone,
Lenalidomide		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Lenalidomide ,
Dexamethasone phosphate 💬 		2件: NR3C1,
TNF 💬 		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16 💬
282Lenalidomide+Dexamethasone2件: Dexamethasone,
Lenalidomide		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Lenalidomide ,
Dexamethasone phosphate 💬 		2件: NR3C1,
TNF 💬 		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16 💬
283Lenalidomide, Dexamethasone2件: Dexamethasone,
Lenalidomide		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Lenalidomide ,
Dexamethasone phosphate 💬 		2件: NR3C1,
TNF 💬 		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16 💬
284Lenalidomide, Dexamethasone and Cyclophosphamide3件: Cyclophosphamide,
Dexamethasone,
Lenalidomide		6件: Cyclophosphamide ,
Dexamethasone ,
Dexamethasone sodium phosphate ,
Lenalidomide ,
Cyclophosphamide ,
Dexamethasone phosphate 💬 		2件: NR3C1,
TNF 💬 		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
285Leniolisib1件: Leniolisib2件: Leniolisib ,
Leniolisib phosphate 💬 		3件: PIK3CA,
PIK3CB,
PIK3CD 💬 		106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬2件: 53, 65 💬
286Leniolisib phosphate1件: Leniolisib2件: Leniolisib ,
Leniolisib phosphate 💬 		3件: PIK3CA,
PIK3CB,
PIK3CD 💬 		106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 65 💬
287Lenogastrim----1件: 28 💬
288Lenograstim1件: Lenograstim1件: Lenograstim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬8件: 2, 13, 16, 18, 19, 57, 65, 97 💬
289Lenrispodun1件: Lenrispodun1件: Lenrispodun 💬 3件: PDE1A,
PDE1B,
PDE1C 💬 		6件: Calcium signaling pathway, Morphine addiction, Olfactory transduction, Purine metabolism, Renin secretion, Taste transduction 💬1件: 6 💬
290Lenti-D Drug Product----1件: 20 💬
291Lentiviral G1XCGD Gene Therapy----1件: 65 💬
292Lentiviral vector containing ABCA4 gene----1件: 301 💬
293Lentiviral vector containing MYO7A gene----2件: 90, 303 💬
294Lentiviral vector containing the ABCA4 gene----1件: 301 💬
295Lentiviral vector containing the human MY07A gene----2件: 90, 303 💬
296Lentiviral Vector Trans-Skip gene modified Autologous Mesoangioblasts----1件: 113 💬
297Lentiviral vector transduced CD34+ cells----1件: 65 💬
298Lentivirus Alpha-gal A transduced stem cells----1件: 19 💬
299Lenzumestrocel1件: Lenzumestrocel---1件: 2 💬
300Leptin1件: Leptin---2件: 6, 265 💬
301Lepunafusp alfa1件: Lepunafusp alfa---1件: 19 💬
302Leqvio----1件: 79 💬
303Leqvio 284 mg solution for injection in pre-filled syringe----1件: 79 💬
304Leramistat----1件: 85 💬
305Leriglitazone1件: Leriglitazone1件: Leriglitazone 💬 1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 20 💬
306Lerodalcibep1件: Lerodalcibep1件: Lerodalcibep 💬 1件: PCSK9 💬 1件: Cholesterol metabolism 💬1件: 79 💬
307Lerodalcibep 300 mg Monthly SC1件: Lerodalcibep1件: Lerodalcibep 💬 1件: PCSK9 💬 1件: Cholesterol metabolism 💬1件: 79 💬
308Letairis----1件: 85 💬
309Letairis 10 mg----1件: 85 💬
310Letairis 5 mg----1件: 85 💬
311Letermovir1件: Letermovir1件: Letermovir 💬 --2件: 60, 85 💬
312Letrozole1件: Letrozole1件: Letrozole 💬 1件: CYP19A1 💬 2件: Ovarian steroidogenesis, Steroid hormone biosynthesis 💬2件: 81, 89 💬
313Leucine1件: Leucine1件: Leucine 💬 --13件: 5, 6, 7, 18, 19, 65, 96, 97, 127, 280, 283, 284, 299 💬
314Leuco-methylthioninium bis(hydromethanesulfonate)1件: Methylthioninium---1件: 127 💬
315Leucovorin1件: Leucovorin3件: Leucovorin calcium ,
Folinic acid ,
Folinic acid calcium salt pentahydrate 💬 		--3件: 13, 19, 46 💬
316Leukapheresis----6件: 49, 51, 85, 96, 284, 285 💬
317LEUKINE----2件: 28, 229 💬
318Leukopheresis----1件: 51 💬
319Leuplin DPS 11.25mg----1件: 76 💬
320Leuprolide1件: Leuprolide3件: Leuprolide acetate ,
Leuprolide ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬5件: 1, 2, 3, 51, 76 💬
321Leuprolide (GnRH agonists)1件: Leuprolide3件: Leuprolide acetate ,
Leuprolide ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
322Leuprolide Acetate (LA)2件: Acetate,
Leuprolide		3件: Leuprolide acetate ,
Leuprolide ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
323Leuprolide Acetate 11.25 MG/ML2件: Acetate,
Leuprolide		3件: Leuprolide acetate ,
Leuprolide ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
324Leuprolide Acetate 3 Month Depot2件: Acetate,
Leuprolide		3件: Leuprolide acetate ,
Leuprolide ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
325Leuprolide Acetate 45 mg2件: Acetate,
Leuprolide		3件: Leuprolide acetate ,
Leuprolide ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
326Leuprolide acetate depot2件: Acetate,
Leuprolide		3件: Leuprolide acetate ,
Leuprolide ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
327Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide1件: Leuprolide3件: Leuprolide acetate ,
Leuprolide ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
328Leuprorelin----2件: 67, 76 💬
329Leuprorelin Acetate2件: Acetate,
Leuprolide		3件: Leuprolide acetate ,
Leuprolide ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬2件: 1, 76 💬
330Leuprorelin Acetate 3.75mg Injection1件: Acetate---1件: 76 💬
331Leuprorelin Acetate Depot 3M1件: Acetate---1件: 76 💬
332Levacetylleucine----1件: 65 💬
333Levact----1件: 61 💬
334Levamidole 50mg----1件: 222 💬
335Levamisole1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--4件: 60, 61, 62, 222 💬
336Levamisole 10 mg1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
337Levamisole 10mg1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
338Levamisole 25 mg1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
339Levamisole 25mg1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
340Levamisole 5 mg1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
341Levamisole 50 mg1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
342Levamisole 5mg1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
343LEVAMISOLE CHLORHYDRATE1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
344Levamisole hydrochloride1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--2件: 60, 222 💬
345Levamisole+cyclosporin A+Glucocorticoids1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--2件: 60, 62 💬
346Levaquin----1件: 84 💬
347Levemir 100 U/ml solution for injection in a cartridge, Levemir 100 U/ml solution for injection in a pre-filled pen----1件: 299 💬
348Levemir FlexPen----1件: 299 💬
349Levemir Penfill----1件: 299 💬
350Levetiracetam1件: Levetiracetam1件: Levetiracetam 💬 1件: SV2A 💬 1件: ECM-receptor interaction 💬7件: 2, 4, 6, 13, 34, 149, 307 💬
351Levitra----2件: 13, 86 💬
352Levobupivacaine1件: Levobupivacaine2件: Levobupivacaine hydrochloride ,
Levobupivacaine 💬 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 46 💬
353Levocarnil----1件: 13 💬
354LEVOCARNITINE1件: Levocarnitine2件: Levocarnitine chloride ,
Levocarnitine 💬 		--3件: 3, 53, 97 💬
355Levocarnitine propyl hydrochloride1件: Levocarnitine2件: Levocarnitine chloride ,
Levocarnitine 💬 		--1件: 97 💬
356LEVOCETIRIZINA DICLORIDRATO----1件: 61 💬
357Levocitirizina----1件: 61 💬
358Levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬8件: 5, 6, 17, 90, 120, 140, 164, 201 💬
359LEVODOPA (DC.IT) (FU)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
360Levodopa (delivered intravenously)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
361Levodopa (drug), intraduodenal administration1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
362Levodopa (L-dopa)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
363Levodopa (L-DOPA) + Standard care1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
364LEVODOPA (LD)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
365Levodopa / Benserazid1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
366LEVODOPA / BENSERAZIDE 200 + 50 MG2件: Benserazide,
Levodopa		3件: Levodopa ,
Benserazide hydrochloride ,
Benserazide 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
367Levodopa / carbidopa solution2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
368Levodopa 100 mg / benserazide 25 mg2件: Benserazide,
Levodopa		3件: Levodopa ,
Benserazide hydrochloride ,
Benserazide 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
369Levodopa 100 mg A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
370Levodopa 125 mg A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
371Levodopa 150 mg A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
372Levodopa 75 mg A CAP1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
373Levodopa acute challenge1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
374Levodopa and carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
375Levodopa and decarboxylase inhibitor1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
376Levodopa and Domperidone2件: Domperidone,
Levodopa		3件: Levodopa ,
Domperidone ,
Domperidone maleate 💬 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
377Levodopa Benserazide Madopar2件: Benserazide,
Levodopa		3件: Levodopa ,
Benserazide hydrochloride ,
Benserazide 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
378Levodopa Benserazide Teva Italia2件: Benserazide,
Levodopa		3件: Levodopa ,
Benserazide hydrochloride ,
Benserazide 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
379Levodopa Carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
380Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
381Levodopa carbidopa intestinal gel (LCIG)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
382Levodopa CR (controlled release)1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
383Levodopa Cyclops1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
384LEVODOPA DC.IT FU1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
385Levodopa dispersible1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
386Levodopa formulation1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
387Levodopa infusion1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
388LEVODOPA INN1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
389Levodopa MR1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
390Levodopa powder for inhalation1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
391Levodopa tablet1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
392Levodopa test1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 17 💬
393Levodopa, carbidopa, entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
394Levodopa, carbidopa, ODM-1042件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
395Levodopa, decarboxylase inhibitor and COMT inhibitor1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
396Levodopa-4'-Monophosphate2件: Foslevodopa,
Levodopa		2件: Levodopa ,
Foslevodopa 💬 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
397Levodopa-Carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬2件: 6, 90 💬
398Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
399Levodopa-Carbidopa Immediate Release2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
400Levodopa-carbidopa Immediate Release (LC-IR) Tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
401Levodopa-Carbidopa Intestinal Gel2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
402Levodopa-Carbidopa Intestinal Gel (LCIG)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
403Levodopa-Carbidopa Multilayer Extended Release Tablet2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
404Levodopa-Carbidopa XL tablet (M)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
405Levodopa-carbidopa-entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
406Levodopa/benserazide2件: Benserazide,
Levodopa		3件: Levodopa ,
Benserazide hydrochloride ,
Benserazide 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
407Levodopa/benserazide 100/25 mg2件: Benserazide,
Levodopa		3件: Levodopa ,
Benserazide hydrochloride ,
Benserazide 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
408LEVODOPA/BENZERASIDE1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
409Levodopa/Benzerazide1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
410LEVODOPA/CARBIDOPA2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬2件: 6, 164 💬
411Levodopa/Carbidopa (4:1)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 201 💬
412Levodopa/Carbidopa (LD/CD)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
413Levodopa/Carbidopa (Sinemet)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
414Levodopa/carbidopa 100/252件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
415Levodopa/carbidopa oral formulation A2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
416Levodopa/carbidopa oral formulation B2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
417Levodopa/Carbidopa Solution2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
418Levodopa/carbidopa solution for SC administration2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
419Levodopa/Carbidopa(200mg/50mg)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
420Levodopa/carbidopa/entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬 		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		18件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
421Levodopa/DDCI1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
422Levodopa/dopa decarboxylase inhibitor1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
423Levofloxacin1件: Levofloxacin2件: Levofloxacin ,
Levofloxacin 💬 		--5件: 46, 53, 63, 84, 299 💬
424LEVOFLOXACIN HEMIHYDRATE1件: Levofloxacin2件: Levofloxacin ,
Levofloxacin 💬 		--1件: 299 💬
425Levofloxacin Kabi1件: Levofloxacin2件: Levofloxacin ,
Levofloxacin 💬 		--1件: 299 💬
426Levofloxacin-Based H. pylori Eradication Therapy1件: Levofloxacin2件: Levofloxacin ,
Levofloxacin 💬 		--1件: 63 💬
427LEVOFOLENE 4 MG 30 CPR----1件: 13 💬
428Levoketoconazole1件: Levoketoconazole1件: Levoketoconazole 💬 3件: CYP11A1,
CYP11B1,
CYP17A1 💬 		6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬1件: 75 💬
429Levoketozonazole----1件: 75 💬
430LEVONORGESTREL1件: Levonorgestrel1件: Levonorgestrel 💬 1件: PGR 💬 5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 13 💬
431LEVOSIMENDAN1件: Levosimendan1件: Levosimendan 💬 2件: PDE3A,
PDE3B 💬 		10件: Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 2, 57 💬
432Levothyroxine1件: Levothyroxine3件: Levothyroxine sodium ,
Levothyroxine ,
Levothyroxine sodium 💬 		2件: THRA,
THRB 💬 		3件: Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬3件: 49, 78, 80 💬
433Levotonine----1件: 97 💬
434LEVOVANOX----2件: 94, 97 💬
435Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 11件: Aminolevulinic acid2件: Aminolevulinic acid hydrochloride ,
Aminolevulinic acid 💬 		--1件: 34 💬
436Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 21件: Aminolevulinic acid2件: Aminolevulinic acid hydrochloride ,
Aminolevulinic acid 💬 		--1件: 34 💬
437Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 31件: Aminolevulinic acid2件: Aminolevulinic acid hydrochloride ,
Aminolevulinic acid 💬 		--1件: 34 💬
438LFB-IgSC----1件: 65 💬
439LFB-R603----1件: 13 💬
440LFB-R603, TGTX1101----1件: 13 💬
441LFD-200----1件: 46 💬
442LFG316----1件: 62 💬
443LGD-4665----1件: 63 💬
444LH VIOLA Supplementation----2件: 96, 97 💬
445Liatermin1件: Liatermin1件: Liatermin 💬 --1件: 6 💬
446Liatermin (r-metHuGDNF)1件: Liatermin1件: Liatermin 💬 --1件: 6 💬
447LIB003----1件: 79 💬
448Liberase Enzyme (Roche)----2件: 85, 229 💬
449Licorice1件: Licorice1件: Glycyrrhiza 💬 --4件: 46, 53, 74, 224 💬
450Lidocaine1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬14件: 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
451Lidocaine 1% Injectable Solution1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬2件: 34, 168 💬
452Lidocaine 2% without vessel constrictor1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 51 💬
453Lidocaine hydrochloride1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 6 💬
454Lidocaine Hydrochloride, Injectable1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 70 💬
455Lidocaine Injection 2%1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 168 💬
456Lidocaine IV1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 298 💬
457Lidocaine patch 5%1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 13 💬
458Lidocaine Releasing Intravesical System - LiRIS®1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 226 💬
459Light box ( Litebook company)----1件: 6 💬
460Light box (Litebook company)----1件: 6 💬
461Ligustrazine1件: Ligustrazine---2件: 46, 296 💬
462Limaprost1件: Limaprost2件: Limaprost ,
Limaprost alfadex 💬 		1件: PTGER1 💬 4件: Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer 💬1件: 70 💬
463LimphoStat-B----1件: 53 💬
464Linaclotide1件: Linaclotide2件: Linaclotide acetate ,
Linaclotide 💬 		1件: GUCY2C 💬 2件: Hormone signaling, Purine metabolism 💬3件: 6, 97, 299 💬
465Linaclotide 290 micrograms1件: Linaclotide2件: Linaclotide acetate ,
Linaclotide 💬 		1件: GUCY2C 💬 2件: Hormone signaling, Purine metabolism 💬1件: 299 💬
466Linerixibat1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
467Linerixibat (GSK2330672) 40 mg1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
468Linerixibat (GSK2330672) 45 mg1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
469Linerixibat (GSK2330672) 45mg1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
470Linez----1件: 299 💬
471LINEZOLID1件: Linezolid1件: Linezolid 💬 --1件: 299 💬
472Lingzhi (Ganoderma)----1件: 6 💬
473Lingzhi and Sen Miao San----1件: 46 💬
474Linoleic acid1件: Linoleic acid---4件: 2, 5, 13, 299 💬
475Linoleic acid supplementation1件: Linoleic acid---1件: 299 💬
476Linoleic Acid/Oleic Acid2件: Linoleic acid,
Oleic Acid		1件: Oleic acid 💬 --1件: 13 💬
477Linperlisib1件: Linperlisib---2件: 61, 283 💬
478Linsitinib1件: Linsitinib1件: Linsitinib 💬 1件: IGF1R 💬 30件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cadherin signaling, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, HIF-1 signaling pathway, Hepatocellular carcinoma, Hormone signaling, Integrin signaling, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 232 💬
479Linvoseltamab1件: Linvoseltamab1件: Linvoseltamab 💬 1件: TNFRSF17 💬 2件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production 💬1件: 28 💬
480Liofen XL----1件: 13 💬
481LIORESAL*50CPR 10MG----1件: 2 💬
482Liothyronine1件: Liothyronine2件: Liothyronine sodium ,
Liothyronine 💬 		2件: THRA,
THRB 💬 		3件: Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬3件: 13, 210, 212 💬
483Liothyronine I 1311件: Liothyronine2件: Liothyronine sodium ,
Liothyronine 💬 		2件: THRA,
THRB 💬 		3件: Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬2件: 210, 212 💬
484Liothyronine sodium1件: Liothyronine2件: Liothyronine sodium ,
Liothyronine 💬 		2件: THRA,
THRB 💬 		3件: Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬1件: 13 💬
485LIPASA----1件: 299 💬
486Lipasa ácida lisosómica, esterasa, colesterol (gen humano LIPA), lipasa ácida lisosómica (gen humano LIPA)----1件: 19 💬
487LIPASE----2件: 298, 299 💬
488Lipase CLEC----1件: 299 💬
489LIPASE LIP2----1件: 299 💬
490Lipase Lip2 from Yarrowia lipolytica----1件: 299 💬
491Lipid Modifying Therapy (LMT)----1件: 79 💬
492Lipid-lowering agents (Artovastatin)----1件: 50 💬
493Lipid-lowering treatments----1件: 79 💬
494Lipid-Modifying Therapy (LMT)----1件: 79 💬
495Lipiodol® Ultra Fluid with surgical glues----1件: 280 💬
496Lipitor----4件: 51, 79, 96, 299 💬
497Lipitor®----2件: 46, 53 💬
498Lipoic acid1件: Lipoic acid1件: Thioctic acid 💬 --6件: 2, 5, 13, 14, 20, 97 💬
499Lipoic acid (LA) with fish oil and LA without fish oil2件: Fish oil,
Lipoic acid		1件: Thioctic acid 💬 --1件: 13 💬
500Lipoic acid and omega-3 fatty acids2件: Lipoic acid,
Omega-3 fatty acids		1件: Thioctic acid 💬 --1件: 13 💬
501Lipoic acid group1件: Lipoic acid1件: Thioctic acid 💬 --1件: 2 💬
502Lipopolysaccharide----1件: 6 💬
503Liposic----1件: 53 💬
504Liposomal aerosol cyclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
505Liposomal Amikacin1件: Amikacin2件: Amikacin sulfate ,
Amikacin 💬 		--1件: 299 💬
506Liposomal Amikacin (Arikace TM)1件: Amikacin2件: Amikacin sulfate ,
Amikacin 💬 		--1件: 299 💬
507Liposomal Amikacin (Arikace™)1件: Amikacin2件: Amikacin sulfate ,
Amikacin 💬 		--1件: 299 💬
508Liposomal amikacin for inhalation1件: Amikacin2件: Amikacin sulfate ,
Amikacin 💬 		--1件: 299 💬
509Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer.1件: Amikacin2件: Amikacin sulfate ,
Amikacin 💬 		--1件: 299 💬
510Liposomal amphotericin B (Ambisome®)1件: Amphotericin B1件: Amphotericin B 💬 --1件: 299 💬
511Liposomal bupivacaine1件: Bupivacaine2件: Bupivacaine hydrochloride ,
Bupivacaine 💬 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬3件: 51, 70, 96 💬
512Liposomal Curcumin1件: Curcumin---1件: 97 💬
513Liposomal Cyclosporine A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
514Liposomal Cyclosporine A 10 mg1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
515Liposomal Cyclosporine A 5 mg1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
516Liposomal Doxorubicin1件: Doxorubicin2件: Doxorubicin hydrochloride ,
Doxorubicin 💬 		--1件: 331 💬
517Liposomal T4N5 lotion----1件: 159 💬
518Liposome encapsulated BoNT-A----1件: 226 💬
519Liposomed polyphenols resveratrol and curcumin2件: Curcumin,
Resveratrol		---1件: 2 💬
520Liposomes----1件: 226 💬
521Lipoxygenase inhibitor----1件: 160 💬
522Liprotamasa----1件: 299 💬
523Liprotamase----2件: 298, 299 💬
524Liprotamase Powder for Oral Solution----1件: 299 💬
525LIQ861 100 µg----1件: 86 💬
526LIQ861 106 µg----1件: 86 💬
527LIQ861 25 µg----1件: 86 💬
528LIQ861 26.5 µg----1件: 86 💬
529LIQ861 50 µg----1件: 86 💬
530LIQ861 53 µg----1件: 86 💬
531LIQ861 75 µg----1件: 86 💬
532LIQ861 79.5 µg----1件: 86 💬
533LIQ861 Inhaled Treprostinil1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
534Liqourice----1件: 75 💬
535Liquid bubble sampling----1件: 162 💬
536Liquigen MCT oil----1件: 6 💬
537Liquorice----1件: 83 💬
538Liraglutide1件: Liraglutide1件: Liraglutide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 6, 13, 75, 77, 193 💬
539Liraglutide Pen Injector [Saxenda]1件: Liraglutide1件: Liraglutide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
540Lirentelimab1件: Lirentelimab1件: Lirentelimab 💬 --1件: 98 💬
541Lirentelimab (AK002)1件: Lirentelimab1件: Lirentelimab 💬 --1件: 98 💬
542LiRIS 400 mg----1件: 226 💬
543LiRIS low dose and LiRIS high dose----1件: 226 💬
544LiRIS®----1件: 226 💬
545LiRIS® 400 mg----1件: 226 💬
546Lisdexamfetamine1件: Lisdexamfetamine2件: Lisdexamfetamine dimesylate ,
Lisdexamfetamine 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
547Lisdexamfetamine sulfate1件: Lisdexamfetamine2件: Lisdexamfetamine dimesylate ,
Lisdexamfetamine 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
548Lisinopril1件: Lisinopril2件: Lisinopril ,
Lisinopril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬9件: 19, 46, 49, 57, 66, 67, 113, 222, 223 💬
549LISINOPRIL ACTAVIS - 10 MG COMPRESSE 10 COMPRESSE IN BLISTER AL/PVC1件: Lisinopril2件: Lisinopril ,
Lisinopril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 223 💬
550Lisinopril Pills1件: Lisinopril2件: Lisinopril ,
Lisinopril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 49 💬
551Lisinopril, losartan, and atorvastatin3件: Atorvastatin,
Lisinopril,
Losartan		6件: Losartan potassium ,
Lisinopril ,
Atorvastatin calcium ,
Atorvastatin ,
Lisinopril ,
Losartan 💬 		3件: ACE,
AGTR1,
HMGCR 💬 		22件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
552Lisparin----1件: 6 💬
553Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field----1件: 13 💬
554LISURIDE1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 86 💬
555Lisuride Hydrogenmaleate1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
556Lisuride Transdermal System1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
557Lisuride TTS1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
558Lisuride TTS 10cm²1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
559Lisuride TTS 20cm²1件: Lisuride1件: Lisuride 💬 3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
560Lithium----5件: 2, 5, 6, 7, 8 💬
561Lithium Apogepha----1件: 2 💬
562Lithium aspartate----1件: 6 💬
563LITHIUM CARBONATE1件: Lithium carbonate1件: Lithium carbonate 💬 --6件: 2, 13, 17, 18, 127, 310 💬
564Lithium Carbonate 400 MG1件: Lithium carbonate1件: Lithium carbonate 💬 --1件: 2 💬
565Lithium Carbonate Capsule1件: Lithium carbonate1件: Lithium carbonate 💬 --1件: 310 💬
566LITHIUM CITRATE1件: Lithium citrate1件: Lithium citrate 💬 --1件: 2 💬
567Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug)----1件: 307 💬
568Lithiumcarbonaat----1件: 2 💬
569Lithiumcarbonaat 400 PCH tabletten----1件: 2 💬
570Litifilimab1件: Litifilimab1件: Litifilimab 💬 --1件: 49 💬
571LITIO CARBONATO----3件: 2, 17, 18 💬
572LIV-GAMMA SN Inj.----1件: 63 💬
573LIV-GAMMA SN Inj.10%----1件: 63 💬
574LIV001----1件: 97 💬
575Livazo 1 mg film-coated tablets----1件: 79 💬
576Livazo 1mg film-coated tablets----1件: 79 💬
577Livazo 2 mg film-coated tablets----1件: 79 💬
578Livazo 2mg film-coated tablets----1件: 79 💬
579Livazo 4 mg film-coated tablets----1件: 79 💬
580Livazo 4mg film-coated tablets----1件: 79 💬
581Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab5件: Bacillus subtilis,
Bortezomib,
Daratumumab,
Dexamethasone,
Enterococcus faecium		5件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib ,
Dexamethasone phosphate ,
Daratumumab 💬 		3件: CD38,
NR3C1,
PSMB5 💬 		15件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬1件: 28 💬
582Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules----1件: 6 💬
583Live Hookworm Larvae----1件: 13 💬
584Live Necator americanus larvae----1件: 13 💬
585Live SK08 powder----1件: 97 💬
586Liver biopsy----3件: 171, 231, 240 💬
587Liver transplantation----1件: 94 💬
588Livmarli----2件: 297, 338 💬
589Livmarli Oral Product----2件: 297, 338 💬
590Livoletide1件: Livoletide---1件: 193 💬
591LIXACOL----1件: 97 💬
592Lixisenatide1件: Lixisenatide1件: Lixisenatide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
593Lixivaptan1件: Lixivaptan1件: Lixivaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
594LJN452----1件: 93 💬
595LJN452, 0,01 mg----1件: 93 💬
596LJN452, 0,03 mg----1件: 93 💬
597LJN452, 0,1 mg----1件: 93 💬
598LJP 394----1件: 49 💬
599LJP394----1件: 49 💬
600Lloprost(Ventavis,BAYQ6252, 10 µg/mL)----1件: 86 💬
601Lloprost(Ventavis,BAYQ6252, 20 µg/mL)----1件: 86 💬
602LM11A-31----1件: 5 💬
603LMI070----2件: 3, 8 💬
604LMT (atorvastatin, simvastatin, or rosuvastatin)3件: Atorvastatin,
Rosuvastatin,
Simvastatin		5件: Simvastatin ,
Rosuvastatin calcium ,
Atorvastatin calcium ,
Atorvastatin ,
Rosuvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 79 💬
605LMT503----2件: 96, 97 💬
606LMTM----1件: 127 💬
607LMTM/TRx0237----1件: 127 💬
608LMWH/Rivaroxaban1件: Rivaroxaban1件: Rivaroxaban 💬 1件: F10 💬 1件: Complement and coagulation cascades 💬1件: 75 💬
609LMX 4 Topical Cream----1件: 256 💬
610LMY-920----1件: 49 💬
611LNG/EE----1件: 67 💬
612LNK01001----2件: 46, 271 💬
613LNK01001 Dose A----1件: 46 💬
614LNK01001 Dose B----1件: 46 💬
615LNP023----7件: 61, 62, 63, 66, 109, 222, 223 💬
616LNP023 HYDROCHLORI----1件: 66 💬
617LNP023 hydrochloride----1件: 223 💬
618LNP023 HYDROCHLORIDE SALT----2件: 62, 223 💬
619LNP1955----1件: 46 💬
620Lo-Ovral Oral Contraceptive Pills----1件: 60 💬
621LO2A eye drops----1件: 53 💬
622LO4AB02----1件: 96 💬
623LO4AB04----1件: 46 💬
624LOBIVON*28CPR 5MG----1件: 167 💬
625Lobster1件: Lobster---1件: 70 💬
626Lobster Device1件: Lobster---1件: 70 💬
627Local Anesthesia (lidocaine hydrochloride)1件: Lidocaine3件: Lidocaine ,
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 6 💬
628Local Trade Name, 2mg----1件: 6 💬
629Local Trade Name, 4mg----1件: 6 💬
630Local Trade Name, 8mg----1件: 6 💬
631Locally approved intravenous contrast medium for contrast enhanced magnetic resonance imaging (MRI)----1件: 13 💬
632LODALÈS®----1件: 6 💬
633Lodosyn----1件: 13 💬
634Lodotra----1件: 41 💬
635Lodotra (delayed release prednisolone)1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
636Lodotra®----1件: 46 💬
637Loestrin (norethindrone acetate and ethinyl estradiol)2件: Acetate,
Estradiol		2件: Estradiol ,
Estradiol hemihydrate 💬 		2件: ESR1,
ESR2 💬 		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 299 💬
638Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol)2件: Acetate,
Estradiol		2件: Estradiol ,
Estradiol hemihydrate 💬 		2件: ESR1,
ESR2 💬 		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬2件: 46, 49 💬
639Lojuxta 10 mg hard capsules----1件: 79 💬
640Lojuxta 20 mg hard capsules----1件: 79 💬
641Lojuxta 5 mg hard capsules----1件: 79 💬
642Lokomat training----1件: 13 💬
643Lomecel-B medicinal signaling cells----1件: 211 💬
644Lomerizine1件: Lomerizine---1件: 124 💬
645LOMITAPIDE1件: Lomitapide2件: Lomitapide ,
Lomitapide mesylate 💬 		1件: MTTP 💬 1件: Fat digestion and absorption 💬1件: 79 💬
646Lomitapide 2mg hard capsules1件: Lomitapide2件: Lomitapide ,
Lomitapide mesylate 💬 		1件: MTTP 💬 1件: Fat digestion and absorption 💬1件: 79 💬
647Lonafarnib1件: Lonafarnib1件: Lonafarnib 💬 2件: FNTA,
FNTB 💬 		1件: Terpenoid backbone biosynthesis 💬2件: 113, 333 💬
648Lonafarnib, Zoledronic Acid, and Pravastatin3件: Lonafarnib,
Pravastatin,
Zoledronic acid		8件: Pravastatin sodium ,
Zoledronic acid ,
Lonafarnib ,
Zoledronate disodium ,
Zoledronate trisodium ,
Pravastatin ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬 		4件: FDPS,
FNTA,
FNTB,
HMGCR 💬 		5件: AMPK signaling pathway, Bile secretion, Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬1件: 333 💬
649Lonapegsomatropin1件: Lonapegsomatropin1件: Lonapegsomatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 276 💬
650Long term follow up in all patients who received SAR422459 in previous study TDU135831件: SAR422459---1件: 301 💬
651Long Term Follow-Up----1件: 169 💬
652Long term oxygen therapy1件: Oxygen1件: Oxygen 💬 --1件: 88 💬
653Long term tapering of prednisolone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
654Long-acting somatostatin1件: Somatostatin1件: Somatostatin 💬 5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 67 💬
655Long-chain n-3 PUFA----1件: 46 💬
656Long-circulating liposomal prednisolone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
657Longeveron Mesenchymal Stem Cells----1件: 211 💬
658Longidaza®----1件: 50 💬
659Lonodelestat1件: Lonodelestat---1件: 299 💬
660LONOTEN----1件: 179 💬
661Lopace----1件: 19 💬
662Loperamide1件: Loperamide2件: Loperamide hydrochloride ,
Loperamide 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 13, 97 💬
663Loperamide hydrochloride1件: Loperamide2件: Loperamide hydrochloride ,
Loperamide 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 97 💬
664Lopinavir1件: Lopinavir1件: Lopinavir 💬 --1件: 265 💬
665Lopinavir/Ritonavir2件: Lopinavir,
Ritonavir		2件: Ritonavir ,
Lopinavir 💬 		--1件: 265 💬
666Lopinavir/ritonavir + nevirapine3件: Lopinavir,
Nevirapine,
Ritonavir		3件: Ritonavir ,
Nevirapine ,
Lopinavir 💬 		--1件: 265 💬
667Lopinavir/ritonavir + zidovudine + lamivudine4件: Lamivudine,
Lopinavir,
Ritonavir,
Zidovudine		4件: Lamivudine ,
Zidovudine ,
Ritonavir ,
Lopinavir 💬 		--1件: 265 💬
668Loratadina Stada1件: Loratadine1件: Loratadine 💬 1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 89 💬
669Loratadina STADA 10 mg1件: Loratadine1件: Loratadine 💬 1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 89 💬
670Loratadine1件: Loratadine1件: Loratadine 💬 1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬5件: 13, 19, 46, 89, 98 💬
671Lorazepam1件: Lorazepam1件: Lorazepam 💬 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬2件: 36, 231 💬
672Lorcaserin1件: Lorcaserin2件: Lorcaserin hydrochloride ,
Lorcaserin hydrochloride hemihydrate 💬 		1件: HTR2C 💬 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 140 💬
673Lorenzo's Oil----1件: 20 💬
674LORTAAN*28CPR RIV DIV 50MG----1件: 167 💬
675Losartan1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
676Losartan and Atenolol or Propranolol3件: Atenolol,
Losartan,
Propranolol		5件: Atenolol ,
Losartan potassium ,
Propranolol hydrochloride ,
Losartan ,
Propranolol 💬 		4件: ADRB1,
ADRB2,
ADRB3,
AGTR1 💬 		25件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 167 💬
677Losartan and nebivolol2件: Losartan,
Nebivolol		4件: Losartan potassium ,
Nebivolol ,
Nebivolol hydrochloride ,
Losartan 💬 		2件: ADRB1,
AGTR1 💬 		24件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 167 💬
678Losartan and other angiotensin receptor blockers1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 19 💬
679Losartan Bluefish 50 mg2件: Bluefish,
Losartan		2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58 💬
680Losartan group1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 223 💬
681Losartan HEXAL1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 36 💬
682LOSARTAN POTASICO1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 179 💬
683LOSARTAN POTASSIUM2件: Losartan,
Potassium		3件: Losartan potassium ,
Losartan ,
Potassium 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬5件: 36, 98, 167, 179, 215 💬
684Losartan potassium 100mg2件: Losartan,
Potassium		3件: Losartan potassium ,
Losartan ,
Potassium 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 223 💬
685Losartan potassium 50mg2件: Losartan,
Potassium		3件: Losartan potassium ,
Losartan ,
Potassium 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 223 💬
686Losartan Tablets & QingReMoShen Granule1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
687Losec----3件: 46, 225, 294 💬
688Losec Capsules 20 mg----1件: 46 💬
689LOSMAPIMOD1件: Losmapimod1件: Losmapimod 💬 4件: MAPK11,
MAPK12,
MAPK13,
MAPK14 💬 		64件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cadherin signaling, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease, Diabetic cardiomyopathy, Dopaminergic synapse, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬2件: 113, 222 💬
690LOU0641件: Remibrutinib1件: Remibrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬2件: 13, 53 💬
691LOU064C1----1件: 13 💬
692Lovastatin1件: Lovastatin1件: Lovastatin 💬 1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬11件: 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
693Lovastatin 60 MG1件: Lovastatin1件: Lovastatin 💬 1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 34 💬
694Lovastatin ™1件: Lovastatin1件: Lovastatin 💬 1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 34 💬
695Lovastatin, then Minocycline/Lovastatin2件: Lovastatin,
Minocycline		3件: Lovastatin ,
Minocycline hydrochloride ,
Minocycline 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 206 💬
696LOVENOX----1件: 327 💬
697LOVOLDYL*30CPR RIV 5MG----1件: 97 💬
698Low antigen content diet----1件: 66 💬
699Low calorie protein substitute----1件: 240 💬
700Low carbohydrate ketogenic diet----1件: 256 💬
701Low copper diet1件: Copper---1件: 171 💬
702Low Dietary Sodium----1件: 49 💬
703Low dose----1件: 97 💬
704Low dose AFFITOPE® PD03A + Adjuvant----1件: 6 💬
705Low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day1件: Vitamin D---1件: 13 💬
706Low Dose Aspirin (162 mg/day)----1件: 13 💬
707Low dose BIBF 1120 twice daily----1件: 85 💬
708Low dose BIBF1120 once daily----1件: 85 💬
709Low Dose Budesonide1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
710Low dose budesonide rectal foam1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
711Low dose budesonide tablet1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
712Low dose cannabis----1件: 13 💬
713Low dose GR1603 in phase ?----1件: 49 💬
714Low dose GR1603 in phase ?b----1件: 49 💬
715Low Dose GT-02287----1件: 6 💬
716Low dose levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
717Low Dose Mesenchymal Stem Cells (MSCs)----1件: 49 💬
718Low Dose MT-1303----1件: 97 💬
719Low Dose MYOBLOC (10,000 Units)----1件: 13 💬
720Low dose naltrexone1件: Naltrexone2件: Naltrexone hydrochloride ,
Naltrexone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 96, 97 💬
721Low dose of BIIL 284 BS tablets----1件: 46 💬
722Low dose of MRM-3379----1件: 206 💬
723Low dose of MRM-3379 Open-Label----1件: 206 💬
724Low dose ORTD-1----1件: 46 💬
725Low dose prednisolone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
726Low dose steroids----1件: 48 💬
727Low dose TSO----1件: 96 💬
728Low dose vehicle control----1件: 46 💬
729Low Dose-VIS649----1件: 66 💬
730Low energy diode Laser----1件: 35 💬
731Low fiber diet----1件: 96 💬
732Low FODMAP----1件: 97 💬
733Low FODMAP diet----1件: 97 💬
734Low immunogenic interferon-beta-1a----1件: 13 💬
735Low molecular weight heparin (enoxeparine)1件: Heparin2件: Heparin sodium ,
Heparin calcium 💬 		1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬1件: 48 💬
736Low Molecular Weight Heparin Calcium Injection2件: Calcium,
Heparin		2件: Heparin sodium ,
Heparin calcium 💬 		1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬1件: 224 💬
737Low Molecular Weight Heparins (LMWHs)----1件: 327 💬
738Low Protein and High Fiber Diet----1件: 97 💬
739Low Residue Diet Intervention----1件: 21 💬
740Low serine diet1件: Serine1件: Serine 💬 --1件: 96 💬
741Low-dose Aldesleukin (Proleukin®)1件: Aldesleukin1件: Aldesleukin 💬 3件: IL2RA,
IL2RB,
IL2RG 💬 		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 49 💬
742Low-Dose CICR-NAM----1件: 97 💬
743Low-dose IL-2----1件: 56 💬
744Low-dose IL-2 administration----1件: 96 💬
745Low-dose interleukin-2----1件: 53 💬
746Low-dose MH002----1件: 97 💬
747Low-dose naltrexone1件: Naltrexone2件: Naltrexone hydrochloride ,
Naltrexone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
748Low-Dose Naltrexone (LDN)1件: Naltrexone2件: Naltrexone hydrochloride ,
Naltrexone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬3件: 13, 46, 49 💬
749Low-Dose REGN4461----1件: 265 💬
750Low-dose rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
751Low-Frequency Electromagnetic Resonance Therapy (LF-EMR)----3件: 13, 46, 49 💬
752Low-Frequency-Only Stimulation----1件: 6 💬
753Low-molecular-weight heparin1件: Heparin2件: Heparin sodium ,
Heparin calcium 💬 		1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬1件: 48 💬
754Low-volume C1-esterase inhibitor----1件: 65 💬
755Loxoprofen1件: Loxoprofen1件: Loxoprofen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 46, 271 💬
756Loxoprofen sodium hydrogel patch1件: Loxoprofen1件: Loxoprofen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
757Loxoprofen sodium tablet1件: Loxoprofen1件: Loxoprofen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
758LP-005 Dose 1 (Single)----1件: 62 💬
759LP-005 Dose 2 (Single)----1件: 62 💬
760LP-005 Dose 3 (Single)----1件: 62 💬
761LP-005 Dose 4 (Single)----1件: 62 💬
762LP-005 Dose 5 (Single)----1件: 62 💬
763LP-005 Dose 6 (Single)----1件: 62 💬
764LP-005 Dose 7 (Multiple)----1件: 62 💬
765LP-005 Dose 8 (Multiple)----1件: 62 💬
766LP-005 Dose 9 (Multiple)----1件: 62 💬
767LP-005 Injection----1件: 62 💬
768LP-08 20mg----1件: 226 💬
769LP-08 80mg----1件: 226 💬
770LP-168 tablet----1件: 13 💬
771LP352----2件: 140, 144 💬
772LP352, bexicaserin1件: Bexicaserin1件: Bexicaserin 💬 1件: HTR2C 💬 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬2件: 140, 144 💬
773LPA1----1件: 85 💬
774LPM3770164 sustained release tablet----1件: 8 💬
775LPM3770164 sustained release tablet simulant----1件: 8 💬
776LPX-TI641----2件: 13, 46 💬
777LT-02----1件: 97 💬
778LT-02 (modified-release PC pellets)----1件: 97 💬
779LTI-031件: LTI-03---1件: 85 💬
780LTP----1件: 86 💬
781LTP001----2件: 85, 86 💬
782LTS 0.25mg----1件: 46 💬
783LTS 0.5mg----1件: 46 💬
784LTS 1.0mg----1件: 46 💬
785Lu 00-800----1件: 6 💬
786LU 70274----1件: 299 💬
787Lu AA24493----1件: 18 💬
788Lu AF28996----1件: 6 💬
789Lu AF82422----2件: 6, 17 💬
790Lu AG06466----1件: 13 💬
791Lu AG13909----2件: 75, 81 💬
792LUBIPROSTONE1件: Lubiprostone1件: Lubiprostone 💬 1件: CLCN2 💬 1件: Mineral absorption 💬5件: 6, 13, 97, 290, 299 💬
793LUCAR-G79D T cells----1件: 49 💬
794Lucen----1件: 113 💬
795Lucentis----1件: 166 💬
796Lucerastat1件: Lucerastat1件: Lucerastat 💬 1件: UGCG 💬 2件: Cornified envelope formation, Sphingolipid metabolism 💬1件: 19 💬
797Lucinactant1件: Lucinactant1件: Lucinactant 💬 --1件: 299 💬
798Lucinactant first1件: Lucinactant1件: Lucinactant 💬 --1件: 299 💬
799Lucrin----1件: 67 💬
800Lulizumab Pegol1件: Lulizumab pegol---1件: 49 💬
801LUM----1件: 299 💬
802LUM/IVA----1件: 299 💬
803LUM/IVA fixed-dose combination----1件: 299 💬
804LUM001----4件: 93, 94, 297, 338 💬
805LUM001 (Maralixibat)1件: Maralixibat2件: Maralixibat ,
Maralixibat chloride 💬 		2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬2件: 297, 338 💬
806LUMACAFTOR1件: Lumacaftor1件: Lumacaftor 💬 1件: CFTR 💬 9件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
807Lumacaftor / ivacaftor2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 9件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
808Lumacaftor plus Ivacaftor2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 9件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
809Lumacaftor Plus Ivacaftor Combination2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 9件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
810Lumacaftor, Ivacaftor Drug Combination2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 9件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
811Lumacaftor-ivacaftor2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 9件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
812Lumacaftor-Ivacaftor treatment2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 9件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
813Lumacaftor/Ivacaftor2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 9件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
814Lumacaftor/ivacaftor 100mg/125mg tablets2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 9件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
815Lumacaftor/ivacaftor 200mg/125mg2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 9件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
816Lumacaftor/ivacaftor 200mg/125mg tablets2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 9件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
817Lumacaftor/ivacaftor 200mg/83mg tablet2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬 		1件: CFTR 💬 9件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
818LUMASIRAN1件: Lumasiran2件: Lumasiran ,
Lumasiran sodium 💬 		1件: HAO1 💬 2件: Glyoxylate and dicarboxylate metabolism, Peroxisome 💬1件: 234 💬
819Lumason® contrast agent----1件: 21 💬
820Lumbar epidural injection----1件: 70 💬
821Lumbar interbody fusion----1件: 70 💬
822Lumbar Interbody Fusion with Autograft----1件: 70 💬
823Lumbar Interbody Fusion with NeoFuse----1件: 70 💬
824Lumbar interlaminar epidural steroid injection----1件: 70 💬
825Lumbar Punction----1件: 8 💬
826Lumbar puncture----9件: 2, 6, 13, 14, 19, 96, 97, 127, 201 💬
827Lumbar puncture and blood withdrawal----1件: 13 💬
828Lumbar puncture for spinal fluid and blood sample----1件: 2 💬
829Lumentin 44----1件: 96 💬
830Lumiracoxib1件: Lumiracoxib1件: Lumiracoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
831Lumizyme®----1件: 256 💬
832Lunasin Regimen----1件: 2 💬
833Lung Clearance Index----1件: 299 💬
834Lung function measurement----1件: 65 💬
835Lung Function Testing----1件: 340 💬
836Lung Spheroid Stem Cells 100 million----1件: 85 💬
837Lung Spheroid Stem Cells 200 million----1件: 85 💬
838Lung stem cells----1件: 85 💬
839Luo-Fu-Shan Plaster----1件: 46 💬
840Luphere depot 3.75mg(Leuprolide acetate 3.75mg)2件: Acetate,
Leuprolide		3件: Leuprolide acetate ,
Leuprolide ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
841Lupron (leuprolide acetate)2件: Acetate,
Leuprolide		3件: Leuprolide acetate ,
Leuprolide ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
842Lupuzor----1件: 49 💬
843Luspatercept1件: Luspatercept1件: Luspatercept 💬 1件: ACVR2B 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬4件: 60, 61, 63, 282 💬
844Luspatercept combine with Deferasirox2件: Deferasirox,
Luspatercept		2件: Deferasirox ,
Luspatercept 💬 		1件: ACVR2B 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 60 💬
845Lusutrombopag1件: Lusutrombopag1件: Lusutrombopag 💬 1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬2件: 60, 63 💬
846Lusutrombopag Oral Tablet1件: Lusutrombopag1件: Lusutrombopag 💬 1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
847Lusvertikimab1件: Lusvertikimab1件: Lusvertikimab 💬 1件: IL7R 💬 7件: Cytokine-cytokine receptor interaction, FoxO signaling pathway, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency 💬1件: 97 💬
848Lutein1件: Lutein---3件: 13, 90, 164 💬
849Lutein (10 or 30 mg/day) capsules1件: Lutein---1件: 90 💬
850Lutein plus Zeaxanthin2件: Lutein,
Zeaxanthin		---1件: 164 💬
851Luteinizing hormone1件: Luteinizing hormone---1件: 254 💬
852Luteinizing hormone-releasing factor1件: Luteinizing hormone---1件: 254 💬
853LUTENYL----1件: 13 💬
854Lutikizumab1件: Lutikizumab1件: Lutikizumab 💬 2件: IL1A,
IL1B 💬 		44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬3件: 46, 96, 97 💬
855Luveris fixed dose----1件: 74 💬
856Luveris increasing dose----1件: 74 💬
857Luvometinib1件: Luvometinib---1件: 34 💬
858Luvometinib Tablets1件: Luvometinib---1件: 34 💬
859LVIVO-TaVec400 product----4件: 11, 13, 49, 300 💬
860LX1606----1件: 97 💬
861LX20061件: LX2006---1件: 18 💬
862LX3305----2件: 46, 161 💬
863LX3305 250 mg capsule----1件: 161 💬
864LX3305 Dihydrate----1件: 46 💬
865LX3305 high dose----1件: 46 💬
866LX3305 low dose----1件: 46 💬
867LX3305 mid dose----1件: 46 💬
868LY-M001 Injection----1件: 19 💬
869LY03003----1件: 6 💬
870LY03003 ( Rotigotine, extended-release microspheres)1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
871LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection)1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
872LY03003( the name of rotigotine)1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
873LY03003(Rotigotine,extended-release microspheres)1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
874LY03009 F1----1件: 6 💬
875LY03009 F2----1件: 6 💬
876LY03009 F3----1件: 6 💬
877LY03009 F4----1件: 6 💬
878LY03017----1件: 6 💬
879LY2127399----3件: 13, 46, 49 💬
880LY2127399 (Tabalumab)1件: Tabalumab1件: Tabalumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 46 💬
881LY2189102----1件: 46 💬
882LY2439821----3件: 46, 107, 271 💬
883LY248686----1件: 13 💬
884LY300164----1件: 6 💬
885LY3009104----10件: 46, 49, 50, 93, 107, 135, 265, 268, 325, 345 💬
886LY3074828----2件: 96, 97 💬
887LY3090106----1件: 53 💬
888LY3090106 - IV----1件: 46 💬
889LY3090106 - SQ----1件: 46 💬
890LY3154207----1件: 6 💬
891LY3337641----1件: 46 💬
892LY3337641 20 mg----1件: 46 💬
893LY3337641 5 mg----1件: 46 💬
894LY3361237----2件: 49, 53 💬
895LY3462817----1件: 46 💬
896LY3471851----2件: 49, 97 💬
897LY3541860----2件: 13, 46 💬
898LY3871801----1件: 46 💬
899LY38849611件: LY3884961---2件: 6, 19 💬
900LY3884963----1件: 127 💬
901LY3884963 (also referred to as PR006A)----1件: 127 💬
902LY3962681----1件: 6 💬
903LY4006896----1件: 6 💬
904LY4213663----1件: 46 💬
905LY4256984----1件: 2 💬
906LY4268989----1件: 97 💬
907LY4298445----2件: 46, 49 💬
908LY4395089----2件: 96, 97 💬
909LY450190----1件: 86 💬
910LYC-30937----1件: 97 💬
911LYC-30937-EC----1件: 97 💬
912Lycium Barbarum----1件: 90 💬
913Lym-X-Sorb powder----1件: 299 💬
914Lymph node and blood sampling----1件: 296 💬
915Lymphocyte immune globulin----1件: 96 💬
916Lymphodepleting Chemotherapy----3件: 49, 51, 300 💬
917Lymphodepleting Conditioning----3件: 11, 13, 14 💬
918Lymphoseek----1件: 46 💬
919Lymphostat B----1件: 63 💬
920LymphoStat-B----1件: 49 💬
921LymphoStat-B (LSB), monoclonal anti-Blys, LSB----1件: 49 💬
922LymphoStat-B TM----1件: 49 💬
923LymphoStat-B®, monoclonal anti-BLyS, LSB, BENLYSTA®----1件: 49 💬
924LYNC-101----1件: 97 💬
925Lyophilised oral capsules with faecal microbiota----1件: 46 💬
926Lyophilized etanercept powder(Yisaipu)2件: Etanercept,
Yisaipu		1件: Etanercept 💬 2件: LTA,
TNF 💬 		66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
927Lyophilized fecal microbiota (LFMT)1件: Fecal microbiota---1件: 97 💬
928Lyrica----1件: 298 💬
929Lyrica®----1件: 298 💬
930LYS-GM101----1件: 19 💬
931LYS-SAF3021件: Olenasufligene relduparvovec---1件: 19 💬
932LYS006----1件: 97 💬
933Lysine1件: Lysine4件: Lysine acetate ,
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬 		--4件: 13, 97, 228, 299 💬
934Lysine-D-Proline-Threonine4件: D-Proline,
Lysine,
Proline,
Threonine		6件: Proline ,
Threonine ,
Lysine acetate ,
Lysine hydrochloride ,
Lysine ,
Lysine hydrochloride 💬 		--1件: 97 💬
935Lysodase----1件: 19 💬
936Lysomucil 10 %----1件: 299 💬
937Lysosomal acid lipase, Esterase cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA)1件: Cholesterol1件: Cholesterol 💬 --1件: 19 💬
938Lysosomal acid lipase, Esterase, cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA)1件: Cholesterol1件: Cholesterol 💬 --1件: 19 💬
939LYT-100----1件: 85 💬
940LZRSE-Col7A1 Engineered Autologous Epidermal Sheets----1件: 36 💬